Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Published comments/rapid response letters
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Berger, J. T.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ACADEMIA AND CLINIC

The Ethics of Deactivating Implanted Cardioverter Defibrillators

right arrow Jeffrey T. Berger, MD

19 April 2005 | Volume 142 Issue 8 | Pages 631-634

Implantable cardioverter defibrillators are life-saving devices for many patients with cardiac disease. Recipients of these devices, nevertheless, often suffer from progressive comorbid and cardiac conditions. Therefore, physicians should anticipate situations in which the defibrillator is no longer desired by the patient or no longer medically appropriate. Near the end of life, many of these patients may decline cardiopulmonary resuscitation. The comanagement of do-not-resuscitate orders and implanted defibrillators can be confusing to patients and physicians alike since the former proscribe the use of electrical cardioversion while the latter provide this precise treatment. Although the use of implanted defibrillators has important ethical implications, few studies have examined these issues, and guidelines have not yet been developed to assist physicians in caring for patients who have received defibrillators. This paper discusses bioethical considerations in disabling implantable cardioverter defibrillators.

Author and Article Information
space

From State University of New York Stony Brook School of Medicine, Stony Brook, New York, and Winthrop University Hospital, Mineola, New York.

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Jeffrey T. Berger, MD, Clinical Ethics, Department of Medicine, Winthrop University Hospital, 222 Station Plaza North, Suite 518, Mineola, NY 11501; e-mail, jberger{at}winthrop.org.


Related articles in Annals:

Articles
Clinical and Economic Implications of the Multicenter Automatic Defibrillator Implantation Trial-II
Sana M. Al-Khatib, Kevin J. Anstrom, Eric L. Eisenstein, Eric D. Peterson, James G. Jollis, Daniel B. Mark, Yun Li, Christopher M. O'Connor, Linda K. Shaw, AND Robert M. Califf
Annals 2005 142: 593-600. [ABSTRACT][SUMMARY][Full Text]  



This article has been cited by other articles:


Home page
AM J HOSP PALLIAT CAREHome page
A. S. Kelley, S. S. Mehta, and M. Carrington Reid
Management of Patients with ICDs at the End of Life (EOL): A Qualitative Study
American Journal of Hospice and Palliative Medicine, December 1, 2009; 25(6): 440 - 446.
[Abstract] [PDF]


Home page
Home Health Care Management PracticeHome page
S. Childress
Ethics at the End of Life
Home Health Care Management Practice, August 1, 2008; 20(5): 414 - 417.
[Abstract] [PDF]


Home page
EuropaceHome page
B. L. Wilkoff, A. Auricchio, J. Brugada, M. Cowie, K. A. Ellenbogen, A. M. Gillis, D. L. Hayes, J. G. Howlett, J. Kautzner, C. J. Love, et al.
HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): Description of Techniques, Indications, Personnel, Frequency and Ethical Considerations: Developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association
Europace, June 1, 2008; 10(6): 707 - 725.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
H. M. Ross
Deactivating Implantable Cardioverter Defibrillators
Ann Intern Med, November 1, 2005; 143(9): 690 - 690.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. Lynn
Deactivating Implantable Cardioverter Defibrillators
Ann Intern Med, November 1, 2005; 143(9): 691 - 691.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. M. Beattie, M. J. Connolly, and J. E. Ellershaw
Deactivating Implantable Cardioverter Defibrillators
Ann Intern Med, November 1, 2005; 143(9): 690 - 691.
[Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

ICD Deactivation: Distinct From Pacemakers
Heather M. Ross
Annals Online, 21 Apr 2005 [Full text]
ICD Deactivation in Advanced Heart Failure
James M Beattie, et al.
Annals Online, 6 May 2005 [Full text]
Consent Should Always Address Stopping an ICD
Joanne Lynn
Annals Online, 16 May 2005 [Full text]
Author's Response
Jeffrey T. Berger
Annals Online, 3 Jun 2005 [Full text]
Re: Author's Response
Eugene B Wu
Annals Online, 30 Jun 2005 [Full text]



 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2005 by the American College of Physicians.